James Gruber

Director of Finance/CFO chez ETON PHARMACEUTICALS, INC.

Fortune : 13 496 $ au 31/03/2024

52 ans

Consumer Services

Health Technology

Postes actifs de James Gruber

Sociétés	Poste	Début	Fin
ETON PHARMACEUTICALS, INC.	Director of Finance/CFO	11/04/2022	-
	Corporate Secretary	11/04/2022	-
	Treasurer	11/04/2022	-

Sociétés	Poste	Début	Fin
Horizon Therapeutics, Inc. Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Horizon Therapeutics is a late stage biopharmaceutical company focused on the development of prescription drugs for mild to moderate pain relief. It is creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance.	Comptroller/Controller/Auditor	-	-

Indiana University	Undergraduate Degree
Kellogg School of Management	Masters Business Admin

Internationale

Etats-Unis

Opérationnelle

Sectorielle

Consumer Services	3
Health Technology	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
ETON PHARMACEUTICALS, INC.	Health Technology

Entreprise privées	1
Horizon Therapeutics, Inc. Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Horizon Therapeutics is a late stage biopharmaceutical company focused on the development of prescription drugs for mild to moderate pain relief. It is creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance.	Health Technology

Entreprise privées

Health Technology